ICON annouced as the Clinical Research Company of the Year

Recently, we published that ICON had increased their expectations for earnings this year. Yesterday, PharmaTimes gave them the award Clinical Research Company of the Year.

The Chief Operating Officer, Alan Morgan, had this to say about the award:

"We are delighted with our success at the PharmaTimes awards, as it recognizes the outstanding contribution that our people have made to the overall success of the organization. ICON has established itself as a global service provider with an excellent level reputation for quality and service, which is down to the effort of our staff. We are very proud of the winners and all of our finalists."

For more information, click here.

Clinical Outsourcing Spend is Going Down

We recently posted that companies have been spending less and less money in clinical outsourcing as many companies are realizing that outsourcing does not necessarily make everything cheaper.

I have come across this post form PharmaTimes and another post from Outsourcing-Pharma and am wondering if this is a growing trend within pharma and biotech companies? I’m curious as to how this sudden change will this affect the future of contract research organizations.